Ruptures of the urinary bladder and urachus are the most frequent cause of uroperitoneum in foals. Surgical correction is often the first treatment choice, however, nonsurgical methods, such as urine...
The objective of this study was to compare small intestinal inflammation with gastric inflammation in horses with and without equine gastric glandular disease (EGGD).
Equine pituitary pars intermedia dysfunction (PPID) is the most common endocrine disease observed in senior horses, affecting 20% to 25% of horses older than 15 years.
Ascorbic acid (AA) is an antioxidant that might be beneficial for adjunctive treatment of sepsis in horses. The optimal dose and effects on oxidative status are unknown.
The global equine healthcare market, which was valued at $2.71 billion in 2022, is expected to grow at a compound annual growth rate (CAGR) of 6.02% from 2023 to 2030 and reach approximately $408...
Equine periodontal disease (EPD) is a painful oral inflammatory syndrome characterized by multifactorial pathogenesis. Although it is well known that bacterial proliferation and consequent gingivitis...
Blood glucose concentration is often measured during an oral glucose test (OGT), but is not thought to aid in diagnosing insulin dysregulation (ID) or pituitary pars intermedia dysfunction...
Respiratory disease is common in the horse population and is often associated with poor performance in equine athletes. Despite their outstanding strength and aerobic capacity, little regard is given...
Additional efficacious immunomodulatory treatment is needed for the management of immune-mediated disease in horses. Mycophenolate mofetil (MMF) is an immunosuppressive drug that warrants assessment...
Horses with severe equine asthma had higher concentrations of MMP-9 in the BALF. This study determined Tregs and inflammatory cytokines in BALF and peripheral blood (PB) of adult horses with mild and...
